Progress and Controversies in Multiple Myeloma

Progress and Controversies in Multiple Myeloma

Novel agents in development for multiple myeloma: CELMoDs, antibody-drug conjugates, and peptidesПодробнее

Novel agents in development for multiple myeloma: CELMoDs, antibody-drug conjugates, and peptides

Antibody-drug conjugates in multiple myeloma: current status and future considerationsПодробнее

Antibody-drug conjugates in multiple myeloma: current status and future considerations

COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costsПодробнее

COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs

COMy 2016 Monoclonal Antibodies - Treatment of MM: LonialПодробнее

COMy 2016 Monoclonal Antibodies - Treatment of MM: Lonial

COMy 2016 Total Therapy of Multiple Myeloma: An Update: BarlogieПодробнее

COMy 2016 Total Therapy of Multiple Myeloma: An Update: Barlogie

Treatment of Metastatic Kidney Cancer - Dr. Mary MacKenzie - Apr 10, 2010Подробнее

Treatment of Metastatic Kidney Cancer - Dr. Mary MacKenzie - Apr 10, 2010

Актуальное